Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36620 | 0.87 | BTN3A1 (0.41) | BTN3A1ALDH1A1ALOX15KMT2ANFE2L2 | |
| SCHEMBL29048951 | 0.79 | — | — | |
| SCHEMBL25405879 | 0.79 | BTN3A1 (0.37) | BTN3A1ALDH1A1ALOX15KMT2A | |
| Ethylene Glycol SCHEMBL20769297 | 0.79 | BTN3A1 (0.37) | BTN3A1ALDH1A1ALOX15KMT2A | |
| SCHEMBL294026 | 0.79 | — | — | |
| SCHEMBL425261 | 0.77 | — | — | |
| 1,4-Butanediol SCHEMBL867063 | 0.75 | SQLE (0.43) | BTN3A1ALDH1A1ALOX15KMT2A | |
| SCHEMBL1076413 | 0.75 | — | — | |
| SCHEMBL293806 | 0.75 | — | — | |
| SCHEMBL29776230 | 0.75 | LSS (0.41) | BTN3A1ALDH1A1ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109476570-B | 6-isopropyl-2, 4-dimethylcyclohexen-1-ol compounds as fragrance ingredients | 奇华顿股份有限公司 | 2022-06-07 | — | — | CN | claimed |
| US-10800722-B2 | 6-isopropyl-2,4-dimethylcyclohexen-1-ol compounds as fragrance ingredients | GIVAUDAN S. A. (CH) | 2020-10-13 | — | — | US | claimed |
| EP-3490966-B1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2020-09-16 | — | — | EP | claimed |
| US-20190233357-A1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2019-08-01 | — | — | US | claimed |
| EP-3490966-A1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | Givaudan SA (CH) | 2019-06-05 | — | — | EP | claimed |
| WO-2018019935-A1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2018-02-01 | — | — | WO | claimed |
| CN-109476570-B | 6-isopropyl-2, 4-dimethylcyclohexen-1-ol compounds as fragrance ingredients | 奇华顿股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-10800722-B2 | 6-isopropyl-2,4-dimethylcyclohexen-1-ol compounds as fragrance ingredients | GIVAUDAN S. A. (CH) | 2020-10-13 | — | — | US | disclosed |
| EP-3490966-B1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2020-09-16 | — | — | EP | disclosed |
| US-20190233357-A1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2019-08-01 | — | — | US | disclosed |
| EP-3490966-A1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | Givaudan SA (CH) | 2019-06-05 | — | — | EP | disclosed |
| WO-2018019935-A1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2018-02-01 | — | — | WO | disclosed |
| WO-2003057677-A1 | ANTI-RETROVIRAL 5,6-DISUBSTITUTED ACYCLOPYRIMIDINE NUCLEOSIDE DERIVATIVES | SYDDANSK UNIVERSITET (DK) | 2003-07-17 | — | — | WO | disclosed |
| EP-0030109-B1 | PROCESS FOR PRODUCING ISOPRENE | KURARAY CO., LTD. (JP) | 1983-10-05 | — | — | EP | disclosed |
| US-4381416-A | Process for producing isoprene | KURARAY CO., LTD. (JP) | 1983-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10800722-B2 | 6-isopropyl-2,4-dimethylcyclohexen-1-ol compounds as fragrance ingredients | TRPA1, TRPV1, NISCH | BTN3A1 2229/4885ALDH1A1 177/4885ALOX15 220/4885 |
| US-20190233357-A1 | 6-ISOPROPYL-2,4-DIMETHYLCYCLOHEXEN-1-OL COMPOUNDS AS FRAGRANCE INGREDIENTS | TRPA1, TRPV1, NISCH | BTN3A1 2229/4885ALDH1A1 177/4885ALOX15 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.